Medtronic’s Valiant Navion Thoracic Stent Graft Cleared in EU
Medtronic received European CE Mark approval to introduce its Valiant Navion thoracic stent graft for treating lesions inside the descending thoracic aorta corresponding to thoracic aortic aneurysms (TAA), blunt tense aortic accidents (BTAI), and penetrating atherosclerotic ulcers (PAU). The device won FDA approval in October of this yr.
The Valiant Navion is especially really useful for sufferers with slender iliac arteries, in whom prior to now advanced minimally invasive get right of entry to may just has been tough and extra procedures could have been required simply to get began.
The new product is according to the Valiant Captivia thoracic stent graft device, however due to its narrower profile permits for stepped forward navigation thru tortuous anatomy. It comes with two other stent configurations: CoveredSeal (proximal lined) and FreeFlo (proximal naked steel). These two choices give physicians a capability to regard a variety of sufferers.
“In clinical practice we often see patients with a wide range of thoracic aortic anatomies. For example, TEVAR in females doubles the risk of needing an adjunctive iliac access procedure, which can potentially add risk, time, and cost to the procedure,” in a broadcast observation mentioned Professor Fabio Verzini, M.D., Ph.D., affiliate professor of Vascular Surgery, University of Turin. “The approval of Valiant Navion gives us the ability to broaden the treatable patient population with thoracic aortic disease, including more female patients and those who were previously considered ineligible for TEVAR with a percutaneous approach.”
Product web page: Valiant Navion…
(serve as(d, s, identity) (file, ‘script’, ‘facebook-jssdk’));